indanidine has been researched along with bay-k-8644 in 3 studies
| Studies (indanidine) | Trials (indanidine) | Recent Studies (post-2010) (indanidine) | Studies (bay-k-8644) | Trials (bay-k-8644) | Recent Studies (post-2010) (bay-k-8644) |
|---|---|---|---|---|---|
| 26 | 0 | 1 | 2,555 | 0 | 144 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biguad, M; Julou-Schaeffer, G; Parratt, JR; Stoclet, JC | 1 |
| de Jonge, A; Thoolen, MJ; Timmermans, PB; van Zwieten, PA; Wilffert, B | 1 |
| Dong, X; Doughty, MB; Miller, DW; Misse, GA; Tessel, RE | 1 |
3 other study(ies) available for indanidine and bay-k-8644
| Article | Year |
|---|---|
Endotoxin-induced impairment of vascular smooth muscle contractions elicited by different mechanisms.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Agonists; Animals; Aorta, Thoracic; Caffeine; Calcimycin; Calcium; Clonidine; Endothelium, Vascular; Endotoxins; In Vitro Techniques; Inositol 1,4,5-Trisphosphate; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nitrendipine; Phenylephrine; Potassium Chloride; Rats; Rats, Inbred Strains; Sarcoplasmic Reticulum | 1990 |
Calcium dependency of vasoconstriction mediated by alpha 1- and alpha 2-adrenoceptors.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Azepines; Blood Pressure; Calcium; Calcium Channel Blockers; Clonidine; Imidazoles; Ion Channels; Nifedipine; Rats; Receptors, Adrenergic, alpha; Regional Blood Flow; Structure-Activity Relationship; Vasoconstriction | 1985 |
Characterization of vascular postsynaptic NPY receptor function and regulation and differential sensitivity of Y1 and Y2 receptor function to changes in extracellular calcium availability and prior in vitro peptide exposure.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Agonists; Animals; Calcium; Clonidine; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Neuropeptide Y; Peptide Fragments; Peptides; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Synapses; Vasoconstrictor Agents | 1993 |